Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Mirrx Therapeutics

2009 FOUNDED
OOB STATUS
1-10 EMPLOYEES
Out of Business LATEST DEAL TYPE
Description

Developer of a technology created to modulate microRNA pathways. The company's technology ensures increased protein production from specific messenger RNA and offer a compound that lowers the risk of unwanted side-effects, enabling customers to get technology that helps in giving the required treatment with lower risk of side effects.

Website
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Primary Office
  • Dandyvej 19
  • 7100 Vejle
  • Denmark
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Mirrx Therapeutics’s full profile, request a free trial.

Mirrx Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 01-Dec-2016 Completed Out of Business
1. Seed Round 04-Feb-2010 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Mirrx Therapeutics Executive Team (1)

Name Title Board
Seat
Contact
Info
Thorleif Møller Ph.D Founder, Board Member & Chief Executive Officer

Mirrx Therapeutics Board Members (6)

Name Representing Role Since Contact
Info
Finn Nielsen MD Self Board Member 000 0000
Søren Morgenthaler Echwald Self Board Member 000 0000

4 Former Board Members

You’re viewing 2 of 6 board members. Get the full list »